The global particle therapy market is projected to reach US$1.3 billion by 2031, driven by the rising incidence of cancer and the need for precise, targeted treatments. Particle therapy, which uses charged particles like protons or heavier ions to destroy cancerous cells, offers a promising solution for treating complex tumors and cancers resistant to traditional radiation. Although high costs and specialized facilities remain challenges, advancements in technology and increasing demand are expected to fuel the market’s growth.